Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Caprius, Inc. Reports Second Quarter Financial Results.


FORT LEE, N.J.--(BUSINESS WIRE)--May 20, 1999--

Caprius, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CAPR CAPR Colegio de Abogados de Puerto Rico (Spanish)
CAPR Civil Air Patrol Regulation
CAPR Computer Assisted Pipeline Review
CAPR Capability Requirement
CAPR Capability Request
) announced today a net loss for its second quarter ended March 31, 1999 of $2,634,002 or $0.36 per share versus a loss of $2,089,034 or $0.28 per share for the comparable quarter of the prior year. The net loss for the quarter included a loss on the sale of the rehabilitation rehabilitation: see physical therapy.  business in the amount of $1,427,487.

Caprius intends to aggressively pursue ways that can maximize In a graphical environment, to enlarge a window to the full size of the screen. See Win Maximize windows.  shareholder value. Caprius is focusing its efforts in identifying a candidate who can help utilize the Company's assets as a vehicle for the enhancement of shareholder value.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement:

The statements made in this press release that are not historical fact are "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
" which are based upon current expectations that include a number of risks and uncertainties. Additional factors that could potentially affect the Company's financial results may be found on the Company's filings with the Securities and Exchange Commission. -0-
                    CAPRIUS, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF OPERATIONS
                              (Unaudited)

                          Three Months Ended      Six Months Ended
                               March 31,              March 31,
                           1999       1998        1999        1998
                         --------------------  ----------------------

Revenues:
  Net patient service
   revenues             $  928,762 $  875,253  $2,073,291  $1,717,363
                         --------------------  ----------------------
     Total revenues        928,762    875,253   2,073,291   1,717,363
                         --------------------  ----------------------

Operating Expenses:
  Cost of service
   operations              887,926    660,016   1,858,601   1,483,500
  Research and
   development              71,478    839,105     496,480   1,399,640
  Purchased research and
   development
   (see note 2)                -      (71,081)        -     7,097,566
  Selling, general and
   administrative        1,142,589  1,611,962   2,011,987   2,817,856
  Provision for bad debt
   and collection costs     (8,486)   125,180     114,534     160,772
  Loss (gain) on sale of
   imaging business            -     (133,889)     12,670     (61,468)
  Loss on sale of
   rehabilitation
   business              1,427,487        -     1,427,487         -
                         --------------------  ----------------------
    Total operating
     expenses            3,520,994  3,031,293   5,921,759  12,897,866
                          --------------------  ----------------------

    Operating income
     (loss) from
     continuing
     operations         (2,592,232)(2,156,040) (3,848,468)(11,180,503)

Other income                 9,000      3,050       9,000       3,050
Interest income              9,684    112,316      25,842     232,443
Interest expense           (60,454)   (48,360)   (119,376)    (81,912)
                         --------------------  ----------------------
  Income (loss) from
   continuing operations
   before minority
   interests, equity in
   loss of subsidiary
   and provision for
   income taxes         (2,634,002)(2,089,034) (3,933,002)(11,026,922)

Equity in net loss of
 unconsolidated
 subsidiary                   -          -           -        (67,358)
                         --------------------  ----------------------

  Loss from continuing
   operations before
   provision for income
   taxes                (2,634,002)(2,089,034) (3,933,002)(11,094,280)

Provision for income
 tax benefit                  -          -           -           -
                         --------------------  ----------------------

  Loss from continuing
   operations           (2,634,002)(2,089,034) (3,933,002)(11,094,280)

Income on disposal of
 discontinued operations      -          -      1,100,000        -
                         --------------------  ----------------------
  Net Loss            $(2,634,002)$(2,089,034)$(2,833,002)$(11,094,280)
                         ====================  ======================

Income (loss) per basic
 and diluted common share:
  Loss from continuing
   operations               $(0.36)    $(0.28)     $(0.53)     $(1.66)
  Income on disposal of
   discontinued
   operations                 -          -           0.15        -
                         --------------------  ----------------------
  Net loss per share        $(0.36)    $(0.28)     $(0.38)     $(1.66)
                         ====================  ======================

Weighted average number
 of common shares
 outstanding             7,369,040  7,340,038   7,369,040   6,682,325
                         ====================  ======================


                   CAPRIUS, INC. AND SUBSIDIARIES

                    CONSOLIDATED BALANCE SHEETS
                            (Unaudited)


                                         March 31,      September 30,
                                           1999             1998
                                      ---------------  --------------
ASSETS

Current Assets:
  Cash and cash equivalents              $ 593,650      $ 1,791,476
  Accounts receivable, net of reserve
   for bad debts of $80,259 at
   March 31, 1999 and $663,314
   at September 30, 1998                   361,925        2,899,282
  Note receivable                          530,000            -
  Inventory                                721,394          720,858
  Other current assets                     535,672          584,875
                                      ---------------  --------------
    Total current assets                 2,742,641        5,996,491
                                      ---------------  --------------

Property and Equipment:
  Medical equipment                      2,026,771        2,145,674
  Office furniture and equipment           257,771          251,199
  Other equipment                        1,516,874        1,518,874
  Leasehold improvements                   855,840        1,153,576
                                      ---------------  --------------
                                         4,657,256        5,069,323
  Less: accumulated depreciation
   and amortization                      1,942,949        1,824,946
                                      ---------------  --------------
    Total property and equipment,
     at cost                             2,714,307        3,244,377
                                      ---------------  --------------

Other Assets:
  Goodwill, net of accumulated
   amortization of $27,007 at
   March 31, 1999 and $2,357,703
   at September 30, 1998                   693,175        1,053,797
  Other intangibles, net of
   accumulated amortization of
   $528,456 at March 31, 1999 and
   $371,698 at September 30, 1998        1,083,920        1,240,678
  Other                                     31,534           32,037
                                      ---------------  --------------
    Total other assets                   1,808,629        2,326,512
                                      ===============  ==============
                                       $ 7,265,577     $ 11,567,380

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
  Accounts payable                       $ 552,156        $ 810,990
  Accrued expenses                         335,401          964,922
  Accrued compensation                     297,807          388,748
  Other current liabilities                   -              53,664
  Current portion of long-term
   debt and capital lease
   obligations                             647,687          915,608
                                      ---------------  --------------
    Total current liabilities            1,833,051        3,133,932
                                      ---------------  --------------

Long-term Debt and Capital Lease
 Obligations, Net of Current Portion     1,039,704        1,207,624

Stockholders' Equity:
  Preferred stock, $.01 par value
   Authorized - 1,000,000 shares
   Issued - Series A, none; Series
   B, convertible, 27,000 shares at
   March 31, 1999 and September 30,
   1998 Liquidation preference
   $2,700,000                            2,700,000        2,700,000
  Common stock, $.01 par value
   Authorized - 50,000,000 shares
   Issued and outstanding - 7,369,040
   at March 31, 1999 and
   September 30, 1998                       73,690           73,690
  Additional paid-in capital            63,561,672       63,561,672
  Accumulated deficit                  (61,940,290)     (59,107,288)
  Treasury stock (22,500 common
   shares, at cost)                         (2,250)          (2,250)
                                      ---------------  --------------
    Total stockholders' equity           4,392,822        7,225,824
                                      ===============  ==============
                                       $ 7,265,577     $ 11,567,380
                                      ===============  ==============
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 20, 1999
Words:936
Previous Article:Sony VAIO Digital Studio PCs; Sony Expands Digital Studio Desktop PC Series With Three New Models Packed With Enhanced AV/IT Functionality.
Next Article:Sony Vaio All-In-One Notebooks; Sony Launches Sleek and Elegant All-In-One, High Performance Notebooks Including a Retail First; A Notebook With a...
Topics:



Related Articles
Faulkner Center to Commence Studies to Evaluate Benefits of Dedicated Breast MRI Utilizing Caprius' Aurora System.
Massachusetts General Hospital to Offer Caprius' Aurora Breast Imaging System in a Revenue Sharing Agreement.
Caprius Announces Successful Launch of Aurora Joint Venture At Englewood Hospital and Medical Center.
Caprius to Pursue New Strategic Alliance for the Sale of Aurora Technology.
Caprius Announces Preliminary Settlement in Shareholder Class Action.
Caprius, Inc. Reports First Quarter Financial Results.
Caprius Announces Sale of Its Technology Assets.
Caprius, Inc. Announces Acquisition of Opus Diagnostics, Inc.
Caprius, Inc. Reports Third Quarter Financial Results.
Insignia Financial reports 2Q earnings.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles